Anhui Huaren Health Pharmaceutical Co., Ltd. (SHE:301408)
China · Delayed Price · Currency is CNY 18.82
-0.63 (-3.24%)
Dec 29, 2025, 4:00 PM EST
SHE:301408 Revenue
Anhui Huaren Health Pharmaceutical had revenue of 1.39B CNY in the quarter ending September 30, 2025, with 26.02% growth. This brings the company's revenue in the last twelve months to 5.15B, up 17.47% year-over-year. In the year 2024, Anhui Huaren Health Pharmaceutical had annual revenue of 4.53B with 19.34% growth.
Revenue (ttm)
5.15B
Revenue Growth
+17.47%
P/S Ratio
1.44
Revenue / Employee
650.05K
Employees
7,930
Market Cap
7.42B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.53B | 734.53M | 19.34% |
| Dec 31, 2023 | 3.80B | 534.74M | 16.39% |
| Jan 1, 2023 | 3.26B | 923.72M | 39.50% |
| Jan 1, 2022 | 2.34B | 407.79M | 21.12% |
| Dec 31, 2020 | 1.93B | 408.55M | 26.84% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| WuXi AppTec | 43.88B |
| Huadong Medicine | 43.09B |
| Yunnan Baiyao Group Co.,Ltd | 40.77B |
| Shanghai Fosun Pharmaceutical (Group) | 39.55B |
| Shenzhen Mindray Bio-Medical Electronics | 33.07B |
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 30.98B |
| Zhejiang NHU Company | 22.47B |
| Aier Eye Hospital Group | 22.17B |